Hoi-Yoon Jung

Chief Executive Officer at NOVMETAPHARMA CO., LTD.

45 year

Consumer Services

Health Technology

Profile

Hoi-Yoon Jung is currently the Co-CEO, Director & Head-Research at NovMetaPharma Co., Ltd.
and the Research & Development Director at NovMetaHealth Co. Ltd.
Additionally, he is a Professor at Pohang University of Science & Technology since 2019.
He holds a doctorate degree from Pohang University of Science & Technology and undergraduate and graduate degrees from Handong Global University.

Hoi-Yoon Jung active positions

Companies	Position	Start
NOVMETAPHARMA CO., LTD.	Chief Executive Officer	-
NovMetaHealth Co. Ltd. NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million.	Chief Tech/Sci/R&D Officer	-
Pohang University of Science & Technology	Corporate Officer/Principal	2018-12-31

All active positions of Hoi-Yoon Jung

Training of Hoi-Yoon Jung

Pohang University of Science & Technology	Doctorate Degree
Handong Global University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hoi-Yoon Jung's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NOVMETAPHARMA CO., LTD.	Health Technology

Private companies	1
NovMetaHealth Co. Ltd. NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million.	Health Technology